Clinical Trials Browser

Phase 3 × Ureteral Neoplasms × Specimen Handling × Clear all

NCT03244384 2026-03-18

AMBASSADOR

Phase 3 Active not recruiting

Ureteral Neoplasms

NCT05092958 2026-03-18

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Phase 3 Active not recruiting

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms